PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION
May 1, 2020, 00:00
10.1016/j.jval.2020.04.503
https://www.valueinhealthjournal.com/article/S1098-3015(20)30691-4/fulltext
Title :
PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30691-4&doi=10.1016/j.jval.2020.04.503
First page :
Section Title :
Open access? :
No
Section Order :
10382